Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ERAP2 | Q6P179 | 9/20 | 0.57 |
| ▸ | IL1RN | P18510 | 7/20 | 0.55 |
| ▸ | ERAP1 | Q9NZ08 | 7/20 | 0.54 |
| ▸ | ANPEP | P15144 | 2/20 | 0.54 |
| ▸ | GHSR | Q92847 | 2/20 | 0.52 |
| ▸ | GRPR | P30550 | 2/20 | 0.52 |
| ▸ | ECE1 | P42892 | 4/20 | 0.52 |
| ▸ | KISS1R | Q969F8 | 2/20 | 0.51 |
| ▸ | LNPEP | Q9UIQ6 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30506400 | 0.96 | ERAP2 (0.56) | ERAP2IL1RNERAP1ANPEPGHSR | |
| SCHEMBL30506397 | 0.92 | ERAP2 (0.59) | ERAP2IL1RNERAP1ANPEPGHSR | |
| SCHEMBL38662537 | 0.91 | IL1RN (0.59) | ERAP2IL1RNERAP1KISS1R | |
| SCHEMBL30506405 | 0.90 | GHSR (0.54) | ERAP2ERAP1ANPEPGHSRGRPR | |
| SCHEMBL30490001 | 0.90 | TP53 (0.57) | ERAP2IL1RNERAP1ANPEPGHSR | |
| SCHEMBL31721034 | 0.90 | GHSR (0.54) | ERAP2ERAP1ANPEPGHSR | |
| SCHEMBL29556143 | 0.89 | ERAP2 (0.59) | ERAP2IL1RNERAP1GRPRKISS1R | |
| SCHEMBL29657706 | 0.89 | ERAP2 (0.63) | ERAP2IL1RNERAP1KISS1R | |
| SCHEMBL31171028 | 0.88 | GHSR (0.58) | ERAP2IL1RNERAP1ANPEPGHSR | |
| SCHEMBL30166489 | 0.88 | ECE1 (0.61) | ERAP2IL1RNERAP1ANPEPECE1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116554268-A | Pancreatic lipase inhibitory peptide and application thereof | 华南理工大学 | 2023-08-08 | — | — | CN | disclosed |